3/19
08:08 am
tara
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support [Yahoo! Finance]
Medium
Report
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support [Yahoo! Finance]
3/19
08:00 am
tara
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
High
Report
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
3/14
08:02 am
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
3/11
08:56 am
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $22.00 price target on the stock.
High
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $22.00 price target on the stock.
3/6
08:12 am
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Medium
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
3/5
09:56 am
tara
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
Medium
Report
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
3/5
08:00 am
tara
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Medium
Report
Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
2/26
08:00 am
tara
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Low
Report
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
2/5
08:00 am
tara
Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Medium
Report
Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
1/13
08:00 am
tara
Protara Highlights Recent Updates and Anticipated 2025 Milestones
Medium
Report
Protara Highlights Recent Updates and Anticipated 2025 Milestones
1/8
08:00 am
tara
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference